29
Views
2
CrossRef citations to date
0
Altmetric
Original Article

The Effects of Various Drugs on Speech

Pages 51-57 | Published online: 03 Jul 2009

References

  • Berry W. R., Aronson A. E., Darley F. L., Goldstein N. P. Effects of Penicillamine Therapy and Low-Copper Diet on Dysarthria in Wilson's Disease. Mayo Clin. Proc 1974; 49: 405–408
  • Cole J. O., Schatzberg A. F. Memory difficulty and tricyclic antidepressants. McLean Hosp. J. 1976; 1: 102–107
  • Cookson I. B. Speech disorder, partial syndrome of Gilles de la Tourette, and drug therapy. Britt. J. Psychiat. 1975; 126: 395–6
  • Crane G. Tardive dyskinesia in patients treated with major neuroleptics, a review of the literature. Amer, J. Psychiat. 1968; 124: 40–48
  • Critchley E. M. R. Peak-dose dysphonia in Parkinsonism. The Lancet March 1977; 6: 544
  • Drachman D. A. Memory and cognitive function in man: does the cholinergic system have a specific role?. Neurology 1976; 27: 783–790
  • Edgell P. G., Peterfy G., Pinter E. J. Lithium toxicity. Lancet 1970; 1: 415–416
  • Findlay L., Fisher K., Clifford Rose F. Dementia in Parkinsonism. Recent Progress in Parkinsons Research, F. Clifford Rose, R Capildeo. Pitman Medical, In Press
  • Fishman B. V., McGlone R. E., Shipp T. The effects of certain drugs on phonation. Journal of Speech and Hearing Research 1971; 14: 301–6
  • Gottschalk L. A., Elliott H. W., Bates D. E., And C AB, LE C. G. Content analysis of speech samples to determine effect of lorazepam on anxiety. Clinical Pharmacology and Therapeutics 1972; 13(3)323–328
  • Gottschalk La. Effects of certain benzodiazepine derivitives on disorganization of thought as manifested in speech. Current Therapeutic Research 1977; 21(2)192–206
  • Granacher R. P., Baldessarini R. J. Physostigmine. Arch. Gen. Psychiatry. 1975; 32: 375–380
  • Jaffe J., Dahlberg C., Luria J., Breskin S., Chorosh J., Lorick E. Speech rhythms in patient monologues: the influence of LSD-25 and Dextroamphetamine. Biological Psychiatry 1972; 4(3)243–6
  • Jaffe J., Dahlberg C.C, Luria J., Breskin S., Chorosh J., Lorick E. Effects of LSD-25 and Dextroamphetamine on speech rhythms in Psychotherapy Dialogues. Biological Psychiatry 1973; 6(1)93–6
  • Leanderson R., Meyerson B. A., Persson A. Effect of L-Dopa on speech in Parkinsonism. J. Neurol. Neurosurg. Psychiat. 1971; 34: 679–681
  • Liuequist R., Linnoila M., Mattila M. J. Effects of two weeks' treatment with chlorimipramine and nortriptyline, alone or in combination with alcohol, on learning and memory. Psychopharmacologia 1974; 39: 181–186
  • Markor G. Neuropathology and Psychiatric Journal 1973; 73: 512–3, Marsden And Parkes. The Lancet, Feb. 7, p. 292
  • Melia P. I. Prophylactic lithium in recurrent effective disorder. 7. Ir. Med. Assoc 1970; 63: 353–357
  • Morrow C. T. Speech in deep-submergence atmospheres. The Journal of Acoustical Society of America 1971; 50: 715–28
  • Nakano K. K., Zubick S. M. H., Tyler H. R. Speech defects of Parkinsonian patients. Neurology 1973; 23: 865–70
  • Perry A., Das P., Clifford Rose F. Speech Assessment in Parkinsonism. Progress in Parkinson's Disease Research, F. Clifford Rose, R Capildeo. Pitman Medical, In Press
  • Portnoy R. A. Hyperkinetic dysarthria as an early indicator of impending tardive dyskinesia. J. Speech Hearing Disorders 1979; 44: 214–19
  • Saunders M. Dysarthria with tricyclic anti-depressants. British Medical Journal 1977; 317(30), July
  • Schatzberg A. F., Cole L. O., Biumer D. P. Speech blockage: a tricyclic side effect. Am. J. Psychiatry 1978; 135(5)600–1
  • Sobell L. C., Sobell M. B. Effects of alcohol on the speech of alcoholics. Journal of Speech and Hearing Research 1972; 15: 861–8
  • Solomon K., Vickers R. Dysarthria resulting from lithium carbonate. JAMA 1975; 231(3)280
  • Westermeyer J. Letters to the Editor. American J. Psychiatry 1978; 135(7)
  • Zeidenberg W., Clark W.C, Jaffe J., Anderson S. W., Chin S, Malitz S. Effect of oral administration of delta tetra hydrocannabinol on memory, speech and perception of thermal stimulation. Comprehensive Psychiatry 1973; 14(6)549–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.